Anpai Health Management Consulting

Anpai Health Management Consulting is a Shanghai-based health management and consulting company founded in 2016. Public disclosures indicate it operates in non-clinical health management, wellness and business consulting, and technical consulting related to biotechnology, pharmaceutical, network, and information technology fields. The company appears to function primarily as a commercial and services subsidiary associated with AnPac Bio rather than as a drug-development biotech with a therapeutic pipeline. In 2021, AnPac Bio increased its ownership stake to 60%, making Anpai Shanghai an acquired subsidiary. Available evidence does not indicate that Anpai itself develops therapeutic products or runs clinical-stage drug programs.